I agree with you that updating the Information Technology Agreement would help you and other companies across the United States access growing foreign markets.
Orrin Hatch
The Public Record
Orrin Hatch was a prominent American attorney and politician who served as a United States Senator from Utah from 1977 to 2019. A member of the Republican Party, Hatch was known for his extensive work on a variety of issues, including healthcare, tax reform, and intellectual property rights. Throughout his tenure, he played a significant role in shaping legislation and was involved in numerous bipartisan efforts.
I rise today in defense of the most fundamental principle on which our Republic was founded--what is rightly recognized as our first freedom--religious liberty. Our fellow citizens today do not think much of Congress. The Gallup…
Concerns about surveillance do not become a stalking horse for digital protectionism.
It is essential to ensure that the ambitious trade negotiations currently under way are successful and that we achieve the best possible outcome for the American people.
China continues to be one of our most important and most challenging trading partners.
I hope you will help push the administration to be a stronger, more public advocate on behalf of renewing Trade Promotion Authority.
It is essential that the Deputy USTR be a powerful advocate for strong intellectual property rights protection.
I intend to vote for them. I have known them for quite a while, to be honest with you, and they are good people.
I will not support an agreement that does not provide for the robust protection of U.S. intellectual property rights.
The Deputy USTR also plays an important role, particularly in formulating U.S. trade policy and advocating on behalf of America's international trade interests.
I know Senator Hatch urged us to have you on the panel, and I am surely glad that he did.
Senator Portman and I have introduced something called the Medicare Better Health Rewards Program.
We have a very important report coming out from the FDA, an amendment that I authored in the FDA Safety and Innovation Act that we passed, that is going to require an action plan for more participation of women in drug clinical trials…
I am grateful to all of you. Your testimony surely hit home here, and we want to do everything we can to help, and we will see what we can do.
It is imperative that the Senate start exercising proper levels of oversight to determine whether or not the law is working as promised.
I think what happens in the Congress is, you get up and there are a whole host of issues on your plate.
Given the current fiscal reality, we have to find ways to provide high quality care at greater value and lower cost, all without adding to the deficit.
Even in Roe v. Wade, the Supreme Court said that the State has unique reasons for restricting abortion because it involves what the Court called 'potential human life.'
I believe that abortion is a unique procedure. As you have said, it is the only procedure that terminates a human life.





